A.I.M.S.BIOTEK Trademark

Trademark Overview

On Thursday, May 10, 2018, a trademark application was filed for A.I.M.S.BIOTEK with the United States Patent and Trademark Office. The USPTO has given the A.I.M.S.BIOTEK trademark a serial number of 87916254. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 24, 2022. This trademark is owned by HEMISPHERX BIOPHARMA, INC.. The A.I.M.S.BIOTEK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; interferons; parenterally administered interferon for use in treating viral diseases and cancer; intranasal solutions for use as a vaccine adjuvant
a.i.m.s.biotek

General Information

Serial Number87916254
Word MarkA.I.M.S.BIOTEK
Filing DateThursday, May 10, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Disclaimer with Predetermined Text"BIOTECH"
Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; interferons; parenterally administered interferon for use in treating viral diseases and cancer; intranasal solutions for use as a vaccine adjuvant

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAIM IMMUNOTECH INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473
Party NameHEMISPHERX BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801
Party NameHEMISPHERX BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Trademark Events

Event DateEvent Description
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021EXTENSION 4 GRANTED
Thursday, June 10, 2021EXTENSION 4 FILED
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Wednesday, December 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2020EXTENSION 3 GRANTED
Monday, November 30, 2020EXTENSION 3 FILED
Monday, November 30, 2020TEAS EXTENSION RECEIVED
Saturday, June 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020EXTENSION 2 GRANTED
Thursday, June 18, 2020EXTENSION 2 FILED
Thursday, June 18, 2020TEAS EXTENSION RECEIVED
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2019EXTENSION 1 GRANTED
Wednesday, December 18, 2019EXTENSION 1 FILED
Wednesday, December 18, 2019TEAS EXTENSION RECEIVED
Wednesday, October 9, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 21, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2019ASSIGNED TO LIE
Wednesday, March 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 6, 2018NON-FINAL ACTION E-MAILED
Thursday, September 6, 2018NON-FINAL ACTION WRITTEN
Friday, August 31, 2018ASSIGNED TO EXAMINER
Saturday, May 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 14, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

biotek viral cancer immune disorders pharmaceutical diseases treatment treating interferon adjuvant